Literature DB >> 31272780

Effectiveness and Safety of Ultrasound Guided Lower Extremity Nerve Blockade in Infragenicular Bypass Grafting for High Risk Patients With Chronic Limb Threatening Ischaemia.

Shinsuke Kikuchi1, Takuya Yamaguchi2, Keisuke Miyake1, Daiki Uchida1, Atsuhiro Koya1, Takafumi Iida2, Atsushi Kurosawa2, Tomoki Sasakawa2, Takayuki Kunisawa2, Nobuyoshi Azuma3.   

Abstract

OBJECTIVES: Surgical revascularisation to accomplish limb salvage remains preferable in some patients with chronic limb threatening ischaemia (CLTI). The aim of this study was to evaluate the effectiveness and safety of ultrasound guided lower extremity nerve blockade (UGNB) in infragenicular bypass surgery (IGBS).
METHODS: This was a single centre, retrospective clinical study. Fifty-nine patients with CLTI (67 limbs) who underwent IGBS under UGNB (femoral and sciatic nerve blockade) at Asahikawa Medical University between January 2012 and December 2017 were compared with patients with CLTI (137 limbs) who underwent IGBS under general anaesthesia (GA) over the same period. Propensity score matching based on pre-operative comorbidities was used to minimise background differences of the two groups.
RESULTS: Fifty-six pairs of CLTIs were matched and analysed (55% dialysis dependent). Procedure duration was similar between the two groups, but intraoperative catecholamine index and intravenous fluid volume were lower with UGNB compared with GA (2.9 ± 4.6 vs. 5.9 ± 6.5; p < .01 and 1831 ± 990 vs. 2335 ± 931 mL; p < .01, respectively). The mean arterial blood pressure during induction of anaesthesia was significantly decreased with GA. Post-operatively, the time period to resume a clear liquid and solid food diet was significantly shorter with UGNB (P<0.01 for both outcome measures). Intravenous fluid volume was significanlty lower, while cardiac complications and delirium, based on the NEECHAM confusion scale, occurred significantly less often with UGNB than GA. These significant differences show advantages of UGNB compared to GA. No mortality or major amputations were observed in either group. Early graft thrombosis was observed in five limbs (8.9%) with UGNB and in four limbs with GA (7.1%) (p = .73).
CONCLUSIONS: UGNB has advantages for intra- and post-operative management and could be a useful method to prevent peri-operative complications for high risk patients with CLTI. To ensure the effectiveness of UGNB for IGBS for future indications, a randomised study is required.
Copyright © 2019 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic limb threatening ischaemia; General anaesthesia; High risk; Infragenicular bypass surgery; Lower extremity nerve blockade

Year:  2019        PMID: 31272780     DOI: 10.1016/j.ejvs.2019.03.023

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  4 in total

1.  Collateral artery bypass in the infrapopliteal segment.

Authors:  Ai Tochikubo; Atsuhiro Koya; Daiki Uchida; Yuki Tada; Shinsuke Kikuchi; Nobuyoshi Azuma
Journal:  J Vasc Surg Cases Innov Tech       Date:  2020-12-29

2.  The Impact of Chronic Limb-Threatening Ischemia on Cardiac Surgery.

Authors:  Naohiro Wakabayashi; Shinsuke Kikuchi; Naoya Kuriyama; Yuta Kikuchi; Masahiro Tsutsui; Hayato Ise; Yuri Yoshida; Daiki Uchida; Atsuhiro Koya; Tomonori Shirasaka; Nobuyoshi Azuma; Hiroyuki Kamiya
Journal:  Front Surg       Date:  2022-04-28

3.  Infrainguinal bypass under triple nerve block in patients with severely compromised left ventricular ejection fraction and chronic limb-threatening ischemia.

Authors:  Muzafar Mamatkulov; Nikolai Naumov; Pavel Kurianov; Alexey Yaroslavsky; Alexey Sergeev; Anastasia Voronova
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-05-21

4.  Outcomes After Receipt of Neuraxial or Regional Anesthesia Instead of General Anesthesia for Lower Limb Revascularization Surgery: Protocol for a Systematic Review and Meta-analysis.

Authors:  Derek J Roberts; Hannah Dreksler; Sudhir K Nagpal; Allen Li; Jeanna Parsons Leigh; Timothy Brandys; Prasad Jetty; Luc Dubois; Henry T Stelfox; Daniel I McIsaac
Journal:  JMIR Res Protoc       Date:  2021-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.